48990 Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Dental 

Sciences Member Conflicts. 

Date: October 9, 2009. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Priscilla B. Chen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4104, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1787, chenp@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–23060 Filed 9–24–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

G—Education. 

Date: November 3–4, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Rockville, 

Rockville, MD 20852. 

Contact Person: Jeannette F Korczak, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8115, Bethesda, MD 20892, 301–496–9767, 

korczakj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 17, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–23059 Filed 9–24–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1336–N] 

Medicare Program; Medicare Provider 

Feedback Group Town Hall Meeting— 

October 29, 2009 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

annual Medicare Provider Feedback 

Group (MPFG) Town Hall meeting. This 

meeting is open to all Medicare Fee-forService (FFS) providers and suppliers 

that participate in the Medicare 

program, including physicians, 

hospitals, home health agencies, thirdparty billers, and interested parties, to 

present their individual views and 

opinions on selected FFS Medicare 

topics. In addition, we will be soliciting 

input on how we can improve 

communications to better serve the 

Medicare providers and suppliers. 

DATES: Meeting Date: The Town Hall 

meeting announced in this notice will 

be held on Thursday, October 29, 2009 

from 2 p.m. to 4 p.m. Eastern Daylight 

Time (EDT). 

Deadlines: 

Deadline for Attendance 

Registration—Registration will be open 

beginning September 28, 2009 and will 

close on October 23, 2009. Registration 

after 5 p.m. EDT on October 23, 2009 

will not be accepted. 

Deadline for Written Feedback— 

Written feedback will be accepted 

through November 6, 2009. 

ADDRESSES: Meeting Location: The 

Town Hall meeting will be held in the 

main auditorium of the central building 

of the Centers for Medicare and 

Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. The 

meeting will also be available by 

teleconference. 

Web sites: 

Meeting Registration: Individuals 

must complete the online registration at 

http://registration.intercall.com/go/ 

cms2. 

Meeting Materials: The meeting 

agenda and discussion material will be 

available to download by October 23, 

2009, at http://www.cms.hhs.gov/center/ 

provider.asp. 

FOR FURTHER INFORMATION CONTACT: 

Colette Shatto, (410) 786–6932. You 

may also send inquiries about this 

meeting by e-mail to MFG@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Since 2005, CMS has held five 

Medicare Provider Feedback Group 

(MPFG) Town Hall meetings. The 

purpose of these meetings is to capture 

individual provider and supplier 

feedback on relevant Fee-for-Service 

(FFS) Medicare policy and operational 

issues. These meetings allow us to 

further advance our efforts to strengthen 

the Medicare program and enhance our 

relationship with providers and 

suppliers. The meetings also provide a 

venue to allow us to continue a process 

of communication with individual 

providers and suppliers through the 

following year. 

II. Meeting Format and Agenda 

The meeting will begin with an 

overview of the goals and objectives of 

the MPFG efforts to gather feedback 

from individual Medicare providers and 

suppliers. This meeting will be held onsite at CMS and by teleconference. The 

meeting is open to the public, but onsite attendance is limited to space 

available. The meeting agenda and 

discussion materials will be available to 

download by October 23, 2009. These 

materials can be located at http:// 

www.cms.hhs.gov/center/provider.asp. 

The feedback provided during this 

meeting will assist us as we evaluate 

FFS Medicare policy, operational issues, 

and CMS’ provider and supplier 

communication activities. Topics to be 

discussed include, but are not limited 

to, 5010, ICD–10, Medicare Contracting 

Reform: Lessons Learned from Medicare 

Administrative Contractor (MAC) 

Implementations, Recovery Audit 

Contractors (RACs), Provider 

Communications, and Program Integrity. 

There will be a discussion session 

that offers meeting participants an 

opportunity to provide feedback on how 

CMS services physicians, providers, and 

suppliers, as well as make suggestions 

on how this process can be improved. 

Time for participants to provide 

feedback will be limited according to 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 48991 

the number of registered participants; 

however, written submissions will be 

accepted. Individuals who wish to 

provide written feedback should e-mail 

their feedback to Colette Shatto at 

MFG@cms.hhs.gov. Written feedback 

will be accepted through November 6, 

2009. Consideration will be given to 

feedback received on the topics 

discussed at the meeting, but written 

responses will not be provided. 

Registered participants from the 

meeting will be included as volunteer 

participants in the MPFG and may be 

contacted throughout the year for 

follow-up meetings to solicit additional 

opinions or clarify any issues that may 

arise from the October 29, 2009 meeting. 

III. Registration Instructions 

The Division of Provider Relations 

and Evaluations, Provider 

Communications Group, Center for 

Medicare Management is coordinating 

the meeting registration. While there is 

no registration fee, individuals must 

register to participate both on-site and 

by teleconference. Individuals must 

complete the on-line registration located 

at http://registration.intercall.com/go/ 

cms2. 

The on-line registration system will 

capture contact information and 

practice characteristics (for example, 

names, e-mail addresses, and provider 

and supplier types). Registration will be 

open beginning September 28, 2009 and 

will close on October 23, 2009. 

Registration after 5 p.m. EDT on October 

23, 2009 will not be accepted. 

The on-line registration system will 

generate a confirmation page to indicate 

the completion of your registration. 

Participants should print this page as 

his or her registration receipt. 

Teleconference instructions will be 

issued as part of the confirmation page 

once participants have registered 

through the on-line registration 

instrument. Seating capacity is limited 

to the first 250 registrants. 

If seating capacity has been reached 

for on-site participants, notification will 

be sent that the meeting has reached 

capacity; however, those wishing to 

participate may still do so by 

teleconference. 

IV. Security, Building, and Parking 

Guidelines 

Because this meeting will be located 

on Federal property, for security 

reasons, any persons wishing to attend 

this meeting must register by 5 p.m. 

EDT on October 23, 2009. Individuals 

who have not registered by the 

registration deadline will not be allowed 

to enter the building to attend the 

meeting or attend the meeting by 

teleconference. 

The on-site check-in for visitors will 

be held from 12:30 p.m. to 1:30 p.m 

EDT. Participants should allow 

sufficient time to go through the 

security checkpoints. It is suggested that 

participants arrive at 7500 Security 

Boulevard no later than 1:30 p.m. EDT 

in order to arrive promptly at the 

meeting by 2 p.m. 

Security measures will include 

inspection of vehicles, inside and out, at 

the entrance to the grounds. In addition, 

all persons entering the building must 

pass through a metal detector. All items 

brought to the building, whether 

personal or for the purpose of the 

meeting, are subject to inspection. In 

order to gain access to the building, 

participants will be required to show a 

government-issued photo identification 

(for example, driver’s license or 

passport), and must be listed on an 

approved security list before persons are 

permitted entrance. Persons not 

registered in advance will not be 

permitted into the CMS building and 

will not be permitted to attend the 

meeting. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for the purpose 

of presentation. 

Individuals requiring sign language 

interpretation or other special 

accommodation must contact the 

Designated Federal Officer specified in 

the ‘‘FOR FURTHER INFORMATION

CONTACT’’ section of this notice by 

October 23, 2009. 

(Catalog of Federal Domestic Assistance 

Program No. 93.774, Medicare— 

Supplementary Medical Insurance Program) 

Dated: September 3, 2009. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E9–22164 Filed 9–24–09; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Anti-Infective Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Anti-Infective 

Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on October 27, 2009, from 8 a.m. 

to 5 p.m. 

Location: Hilton Washington DC/ 

Silver Spring, The Ballrooms, 8727 

Colesville Rd., Silver Spring, MD. The 

hotel phone number is 301–589–5200. 

Contact Person: Minh Doan, Center 

for Drug Evaluation and Research (HFD– 

21), Food and Drug Administration, 

5600 Fishers Lane (for express delivery, 

5630 Fishers Lane, rm. 1093) Rockville, 

MD 20857, 301–827–7001, FAX: 301– 

827–6776, e-mail: 

minh.doan@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington DC area), code 3014512530. 

Please call the Information Line for upto-date information on this meeting. A 

notice in the Federal Register about last 

minute modifications that impact a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. Therefore, you should 

always check the agency’s Web site and 

call the appropriate advisory committee 

hot line/phone line to learn about 

possible modifications before coming to 

the meeting. 

Agenda: The committee will discuss 

biologics license application (BLA) 

125349, for raxibacumab injection, 

manufactured by Human Genome 

Sciences, Inc., proposed for the 

treatment of inhalational anthrax 

disease. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before October 16, 2009. 

Oral presentations from the public will 


jlentini on DSKJ8SOYB1PROD with NOTICES